Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosis. (2017)
Attributed to:
Development of a rapid bacterial identification method based on direct mass spectrometric metabolic profiling
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/femsle/fnx121
PubMed Identifier: 28854668
Publication URI: http://europepmc.org/abstract/MED/28854668
Type: Journal Article/Review
Volume: 364
Parent Publication: FEMS microbiology letters
Issue: 14
ISSN: 0378-1097